Clinical Trials · NCT01871844
ITF2984 Repeated Doses Study in Healthy Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Italfarmaco
- Enrollment
- 46
- Start date
- Jan 2012
- Locations
- 2 sites, Italy, United Kingdom
- Primary endpoint
- To evaluate the effects of ITF2984 on GH, insulin, glucagon and glucose after exogenous stimulus